| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |